Abstract 8452: Beta-Blocker Therapy and Atrioventricular Conduction Outcomes in Heart Failure with Reduced Ejection Fraction and Fascicular Block
Background: Beta-blockers are a cornerstone of guideline-directed medical therapy for heart failure with reduced ejection fraction (HFrEF). However, their safety in patients with pre-existing fascicular or bundle-branch block remains uncertain because of potential adverse effects on atrioventricular (AV) conduction....